151 related articles for article (PubMed ID: 23470427)
1. Analytical and clinical validation of the Immulite 1000 hCG assay for quantitative analysis in urine.
Cate FL; Moffett C; Gronowski AM; Grenache DG; Hartmann KE; Woodworth A
Clin Chim Acta; 2013 Jun; 421():104-8. PubMed ID: 23470427
[TBL] [Abstract][Full Text] [Related]
2. Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine.
Woldemariam GA; Butch AW
Clin Chem; 2014 Aug; 60(8):1089-97. PubMed ID: 24899693
[TBL] [Abstract][Full Text] [Related]
3. Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use.
Butch AW; Ahrens BD; Avliyakulov NK
Drug Test Anal; 2018 Jun; 10(6):956-960. PubMed ID: 29098788
[TBL] [Abstract][Full Text] [Related]
4. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
Butch AW; Woldemariam GA
Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
[TBL] [Abstract][Full Text] [Related]
5. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
[TBL] [Abstract][Full Text] [Related]
6. Estimating the hCGβcf in urine during pregnancy.
Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
[TBL] [Abstract][Full Text] [Related]
7. Quantitative, wide-range, 5-minute point-of-care immunoassay for total human chorionic gonadotropin in whole blood.
von Lode P; Rainaho J; Pettersson K
Clin Chem; 2004 Jun; 50(6):1026-35. PubMed ID: 15073089
[TBL] [Abstract][Full Text] [Related]
8. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
Nerenz RD; Song H; Gronowski AM
Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
[TBL] [Abstract][Full Text] [Related]
9. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives.
Berger P; Sturgeon C; Bidart JM; Paus E; Gerth R; Niang M; Bristow A; Birken S; Stenman UH
Tumour Biol; 2002; 23(1):1-38. PubMed ID: 11893904
[TBL] [Abstract][Full Text] [Related]
10. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
Milhorn D; Korpi-Steiner N
Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
[TBL] [Abstract][Full Text] [Related]
11. Rapid, automated quantification of total human chorionic gonadotropin in serum by a chemiluminescent enzyme immunometric assay.
Vankrieken L; De Hertogh R
Clin Chem; 1995 Jan; 41(1):36-40. PubMed ID: 7529145
[TBL] [Abstract][Full Text] [Related]
12. Determination of human chorionic gonadotropin.
Stenman UH; Alfthan H
Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):783-93. PubMed ID: 24275190
[TBL] [Abstract][Full Text] [Related]
13. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.
Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S
Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148
[TBL] [Abstract][Full Text] [Related]
14. Analytical performance evaluation of the i-STAT Total β-human chorionic gonadotropin immunoassay.
Sowder AM; Yarbrough ML; Nerenz RD; Mitsios JV; Mortensen R; Gronowski AM; Grenache DG
Clin Chim Acta; 2015 Jun; 446():165-70. PubMed ID: 25916696
[TBL] [Abstract][Full Text] [Related]
15. Persistently elevated serum concentrations of human chorionic gonadotropin (hCG).
Collazo Abal C; Fernández Marcos MC; Casado Rey P; Vázquez Caamaño MP; Alfthan H; Koistinen H; Stenman UH
Clin Chem Lab Med; 2023 Oct; 61(11):2028-2032. PubMed ID: 37279342
[TBL] [Abstract][Full Text] [Related]
16. The need for a quantitative urine hCG assay.
Cole LA; Khanlian SA
Clin Biochem; 2009 May; 42(7-8):676-83. PubMed ID: 19026624
[TBL] [Abstract][Full Text] [Related]
17. Quantitative automated human chorionic gonadotropin measurement in urine using the Modular Analytics E170 module (Roche).
Ajubi NE; Nijholt N; Wolthuis A
Clin Chem Lab Med; 2005; 43(1):68-70. PubMed ID: 15653445
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
Robinson N; Sottas PE; Saugy M
Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
[TBL] [Abstract][Full Text] [Related]
19. Characterizing urinary hCGβcf patterns during pregnancy.
Nerenz RD; Yarbrough ML; Stenman UH; Gronowski AM
Clin Biochem; 2016 Jul; 49(10-11):777-81. PubMed ID: 27087510
[TBL] [Abstract][Full Text] [Related]
20. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
